In8Bio (INAB) Other financing activities (2021 - 2025)

In8Bio has disclosed Other financing activities across 5 years of filings, most recently posting $16.6 million for Q4 2025.

• In Q4 2025, Other financing activities rose 619.35% year-over-year to $16.6 million; the TTM figure through Jun 2026 stood at $16.6 million (up 108.08% YoY), while the FY2025 annual figure was $18.5 million, up 201.96% from the prior year.
• Other financing activities came in at $16.6 million for Q4 2025 at In8Bio, up from $1.5 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $16.6 million in Q4 2025 to a low of -$36.3 million in Q4 2021.
• Average Other financing activities over 5 years is -$775785.7, with a median of $552500.0 recorded in 2023.
• Year-over-year, Other financing activities jumped 41710.71% in 2023 and tumbled 99.79% in 2024.
• Over 5 years, Other financing activities stood at -$36.3 million in 2021, then soared by 74.0% to -$9.4 million in 2022, then surged by 56.2% to -$4.1 million in 2023, then soared by 155.89% to $2.3 million in 2024, then surged by 619.35% to $16.6 million in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $16.6 million in Q4 2025, $1.5 million in Q2 2025, and $383000.0 in Q1 2025.